Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects
出版年份 2020 全文链接
标题
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects
作者
关键词
-
出版物
Clinical Pharmacology in Drug Development
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-10-08
DOI
10.1002/cpdd.874
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor
- (2019) Junliang Hao et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Dopamine D1 Receptor Partial Agonist, PF-06669571, in Subjects with Idiopathic Parkinson’s Disease
- (2018) Rachel Gurrell et al. CLINICAL DRUG INVESTIGATION
- Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders
- (2018) Robert F. Bruns et al. NEUROPHARMACOLOGY
- Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
- (2018) David L. Gray et al. Nature Communications
- Dopamine: Functions, Signaling, and Association with Neurological Diseases
- (2018) Marianne O. Klein et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Novel Strategies To Activate the Dopamine D1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation
- (2018) Adrian Hall et al. JOURNAL OF MEDICINAL CHEMISTRY
- The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice
- (2018) Herbert Y. Meltzer et al. BEHAVIOURAL BRAIN RESEARCH
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia
- (2017) Andreas Dammann Andersen et al. JOURNAL OF NEUROCHEMISTRY
- The Neurobiology of Thought: The Groundbreaking Discoveries of Patricia Goldman-Rakic 1937-2003
- (2013) A. F. T. Arnsten CEREBRAL CORTEX
- Control of Sleep and Wakefulness
- (2012) Ritchie E. Brown et al. PHYSIOLOGICAL REVIEWS
- The waking brain: an update
- (2011) Jian-Sheng Lin et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Dopamine and Vascular Dynamics Control: Present Status and Future Perspectives
- (2011) Seyed Khosrow Tayebati et al. CURRENT NEUROVASCULAR RESEARCH
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder
- (2010) Gary Stiefel et al. DRUG SAFETY
- Dopamine Receptors
- (2010) Chunyu Zeng et al. HYPERTENSION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started